Charitable trust registration requires a specified-violation notice; settled cash deposits and related-party payments did not justify cancellation or ...
External development charges trigger TDS under section 194C, while disputed administrative payments require factual verification and fresh adjudicatio...
Section 270AA penalty immunity requires identified statutory defaults and a hearing before rejection; reassessment disclosure may constitute under-rep...
Section 80JJAA employee-cost deduction allowed for deployed staff but barred against transfer-pricing income enhancement, with pricing issues remanded...
Transfer-pricing methodology protects commercially genuine associated-enterprise payments, while pre-2016 secondary adjustments and related notional i...
Negative liens over operating assets can constitute international transactions requiring arm's-length pricing reflecting restricted borrowing and expa...
Cross-examination rights in Customs Broker revocation inquiries require witness examination; procedural denial may be cured through fresh adjudication...
The DGFT issued a public notice establishing a new Standard Input Output Norm (SION) A-3685 for Doxycycline 100 mg Dispersible Tablets under the Chemical and Allied Product category. The notice specifies that for each tablet export, 106.13 mg of Doxycycline Monohydrate U.S.P/B.P is permitted as an import input. This regulatory directive, exercised under paragraph 1.03 of the Foreign Trade Policy-2023, provides standardized guidelines for the pharmaceutical product's import-export parameters, facilitating streamlined trade documentation and compliance for manufacturers and exporters.
The DGFT issued a public notice establishing a new Standard Input Output Norm (SION) A-3685 for Doxycycline 100 mg Dispersible Tablets under the Chemical and Allied Product category. The notice specifies that for each tablet export, 106.13 mg of Doxycycline Monohydrate U.S.P/B.P is permitted as an import input. This regulatory directive, exercised under paragraph 1.03 of the Foreign Trade Policy-2023, provides standardized guidelines for the pharmaceutical product's import-export parameters, facilitating streamlined trade documentation and compliance for manufacturers and exporters.
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
TaxTMI 
of 4828 
Join Channel 
